Skip to main content
Amoy Diagnostics Co.,Ltd. logo

Amoy Diagnostics Co.,Ltd. — Investor Relations & Filings

Ticker · 300685 ISIN · CNE1000034D3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,089 across all filing types
Latest filing 2018-10-29 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 300685

About Amoy Diagnostics Co.,Ltd.

https://www.amoydx.com

Amoy Diagnostics Co., Ltd. specializes in the development and commercialization of molecular diagnostic products for precision oncology. The company provides a comprehensive portfolio of testing kits designed to identify genetic mutations and biomarkers essential for personalized cancer treatment. Its core technology platforms include the proprietary ADx-ARMS, Super-ARMS, and specialized Next-Generation Sequencing (NGS) solutions. AmoyDx focuses on companion diagnostics (CDx), collaborating extensively with global pharmaceutical companies to integrate diagnostic testing into clinical drug development and patient management. Key products cover a wide range of solid tumors, including lung, colorectal, and breast cancers, facilitating targeted therapy selection and monitoring. The company maintains rigorous quality standards, with numerous products receiving regulatory approvals for clinical use in multiple international markets.

Recent filings

Filing Released Lang Actions
2018年第三季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2018 Third Quarter Report" of 厦门艾德生物医药科技股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as balance sheets, profit and loss statements, cash flow statements, and explanations of financial changes during the quarter. The document includes comprehensive financial metrics, shareholder information, and notes on important events during the reporting period. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is a full interim/quarterly report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2018
2018-10-29 Chinese
关于2018年第三季度报告披露的提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (339 characters) stating that the company's 2018 third quarter report has been disclosed on the official stock exchange website. It does not contain the actual financial data or report itself, but rather informs investors where to find the full report. This fits the pattern of a Report Publication Announcement (RPA) rather than the actual Interim/Quarterly Report (IR).
2018-10-29 Chinese
第二届董事会第三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from Xiamen Aide Biomedical Technology Co., Ltd. It reports the approval of the 2018 third quarter report by the board of directors, including voting results and meeting details. The document does not contain the actual financial statements or detailed financial data of the quarterly report but refers to the report being available on the designated disclosure website and in newspapers. The document length is short (695 characters), and it serves as an announcement of the board meeting decision rather than the report itself. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of board decisions and management matters.
2018-10-29 Chinese
关于媒体报道的说明公告
Legal Proceedings Report Classification · 95% confidence The document is a public announcement from a company regarding an administrative penalty imposed by a regulatory authority (the Ministry of Science and Technology of China). It explains the nature of the penalty, the company's response, and reassures investors about the impact on operations. The document does not contain financial statements, audit results, or detailed financial data. It is not a report but a regulatory announcement about a legal/regulatory matter. Therefore, it fits best under the category of Legal Proceedings Report (LTR). The document length is short and it is not an announcement of a report publication, so RPA is not appropriate. It is not a certification or attestation, so RNS is less suitable than LTR, which specifically covers legal and regulatory updates.
2018-10-26 Chinese
关于子公司上海厦维引入员工持股平台进行增资的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Xiamen Aide Biomedical Technology Co., Ltd. regarding the progress of capital increase in its subsidiary Shanghai Xiangwei through the introduction of an employee stock ownership platform. It details the increase in registered capital, shareholding proportions, and completion of related business registration procedures. The document is an update on financing activity related to capital structure changes and employee incentive mechanisms. It is not a full financial report, audit, or earnings release, nor is it a regulatory certification or voting result. The content fits the category of Capital/Financing Update (CAP). The document length is short and focused on a specific financing event, not a report publication or regulatory filing. Therefore, the classification is CAP with high confidence.
2018-10-24 Chinese
关于使用闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the progress and details of using idle raised funds for cash management, including information about purchasing and redeeming financial products. It contains specific dates, amounts, and risk control measures related to the use of idle raised funds. The document is not a full financial report, earnings release, or management discussion, but rather a regulatory announcement about the company's financing activities and fund management. It does not contain comprehensive financial statements or detailed financial analysis. The document length is about 5900 characters, which is relatively short and focused on a specific financing-related update. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2018-10-24 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.